Tempus receives US FDA 510(k) clearance for AI product intended to detect signs of pulmonary hypertension from standard ECGs: Chicago Wednesday, August 26, 2026, 18:00 Hrs [IST] T ...
Antengene receives Australian approval for phase I ATTRACT study of ATG-201 in B cell-related autoimmune diseases: Shanghai Wednesday, August 26, 2026, 17:00 Hrs [IST] Antengene C ...
RDCA directs retail chemists to comply with Delhi DC dept advisory on discount boards: Peethaambaran Kunnathoor, Chennai ...
Insmed’s Brinsupri receives Japanese approval to treat patients with non-cystic fibrosis bronchiectasis: Bridgewater, New Jersey Wednesday, August 26, 2026, 16:00 Hrs [IST] Insm ...
Entod Pharma announces Project AXIOM, an India-led research programme in myopia therapeutics: Our Bureau, Mumbai Wednesday, August 26, 2026, 16:30 Hrs [IST] On the occasion of Ind ...
Govt closely monitoring seasonal influenza trends across the country: Our Bureau, Mumbai Wednesday, August 26, 2026, 15:50 Hrs [IST] The Union ministry of health and family welfar ...
Alembic Pharma receives Asia Book of Records for screening 40,468 patients for blood pressure in a fortnight: Our Bureau, Mumbai Wednesday, August 26, 2026, 15:30 Hrs [IST] A larg ...
Labcorp to offer Elecsys pTau-217 test, an US FDA-cleared blood test to detect Alzheimer's disease pathology in both primary and specialty care settings: Burlington, North Carolin ...
Celltrion launches 300 mg strength of Omlyclo in Europe to treat chronic spontaneous urticaria and allergic asthma: Incheon, South Korea Wednesday, August 26, 2026, 15:00 Hrs [IST ...
J&J announces US FDA approves Imaavy as first-ever treatment for warm autoimmune haemolytic anaemia: Spring House, Pennsylvania Wednesday, August 26, 2026, 14:00 Hrs [IST] Johnson ...
Dr Jitendra Singh emphasises integration of traditional knowledge with modern science and medicine: Our Bureau, Mumbai Wednesday, August 26, 2026, 15:40 Hrs [IST] Traditional know ...
Piramal Alternatives, the fund management division of the Piramal Group, announced an investment of Rs. 215 crore in Kolors Healthcare India Pvt. Ltd., one of the market leaders in wellness chain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results